5/14
12:10 am
vstm
Verastem, Inc. (NASDAQ: VSTM) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Verastem, Inc. (NASDAQ: VSTM) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
5/13
08:09 am
vstm
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Medium
Report
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
5/9
04:02 pm
vstm
Verastem Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates
Low
Report
Verastem Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates
5/7
07:30 am
vstm
Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference
Low
Report
Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference
4/18
04:09 pm
vstm
Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer [Yahoo! Finance]
Medium
Report
Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer [Yahoo! Finance]
4/18
04:05 pm
vstm
Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer
Medium
Report
Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer
4/11
08:14 am
vstm
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer [Yahoo! Finance]
Low
Report
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer [Yahoo! Finance]
4/11
08:14 am
vstm
MPM BioImpact Appoints Frank Neumann, M.D., Ph.D., Distinguished Expert in Clinical Development, as Entrepreneur Partner [Yahoo! Finance]
Low
Report
MPM BioImpact Appoints Frank Neumann, M.D., Ph.D., Distinguished Expert in Clinical Development, as Entrepreneur Partner [Yahoo! Finance]
5/9/2024
04:02 pm
VSTM
verastem, inc.
BEAT
Report
-0.6%
verastem, inc.
3/14/2024
04:05 pm
VSTM
verastem, inc.
MISS
Report
4.8%
verastem, inc.
11/8/2023
04:12 pm
VSTM
verastem, inc.
BEAT
Report
-5.7%
verastem, inc.
5/9
04:11 pm
vstm
Form 10-Q Verastem, Inc. For: Mar 31
Low
Report
Form 10-Q Verastem, Inc. For: Mar 31
4/12
04:05 pm
vstm
Form DEF 14A Verastem, Inc. For: May 23
Low
Report
Form DEF 14A Verastem, Inc. For: May 23
4/9
05:11 pm
vstm
Form 8-K Verastem, Inc. For: Apr 09
Low
Report
Form 8-K Verastem, Inc. For: Apr 09
4/8
04:30 pm
vstm
Form 4 Verastem, Inc. For: Apr 05 Filed by: Calkins Daniel
Low
Report
Form 4 Verastem, Inc. For: Apr 05 Filed by: Calkins Daniel
3/27
04:31 pm
vstm
Form 4 Verastem, Inc. For: Mar 25 Filed by: Calkins Daniel
Low
Report
Form 4 Verastem, Inc. For: Mar 25 Filed by: Calkins Daniel
3/21
04:33 pm
vstm
Form 4 Verastem, Inc. For: Mar 20 Filed by: Calkins Daniel
Low
Report
Form 4 Verastem, Inc. For: Mar 20 Filed by: Calkins Daniel
3/20
05:37 pm
vstm
Form 4 Verastem, Inc. For: Mar 18 Filed by: Gagnon Robert E.
Low
Report
Form 4 Verastem, Inc. For: Mar 18 Filed by: Gagnon Robert E.
3/20
05:34 pm
vstm
Form 4 Verastem, Inc. For: Mar 18 Filed by: Paterson Dan
Low
Report
Form 4 Verastem, Inc. For: Mar 18 Filed by: Paterson Dan
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register